Dr Singh, MDThe Functional MDs · Medical Doctor

Science of Latest Weight Loss Drugs

Name: Science of Latest Weight Loss Drugs
Uploaded: 2024-04-14T22:00:54+00:00
Duration: 55 s
Channel: Dr Singh, MD
Description: In this concise explanatory video, Dr. Singh, MD, outlines how the GLP‑1 receptor agonist semaglutide and the newer dual GIP/GLP‑1 agonist Mounjaro…

14 Apr 2024 · 1 min

Watch on YouTube

0:55

In this concise explanatory video, Dr. Singh, MD, outlines how the GLP‑1 receptor agonist semaglutide and the newer dual GIP/GLP‑1 agonist Mounjaro promote weight loss. He describes four key physiological actions: (1) stimulation of pancreatic insulin secretion, which lowers blood glucose; (2) slowing of gastric emptying, which prolongs the presence of food in the stomach and increases satiety; (3) suppression of glucagon, reducing hepatic glucose output; and (4) the combined effect of more insulin, slower gastric emptying, increased fullness, and less liver‑derived sugar. He concludes that this combination creates an optimal metabolic environment for weight loss.

Chapters

You have probably heard of semaglutide, which is taking the weight loss and diabetes management communities by storm. And then there's a new kid on the block, Mounjaro. First, they stimulate the secretion of insulin from your pancreas, which lowers your blood sugar levels. Then they slow down your gastric emptying, which is the process of moving food out of your stomach and into your small intestine. Additionally, These drugs also suppress the hormone called glucagon, which is a hormone that signals your liver to release stored sugar into your bloodstream. Now let's combine all these actions together. More insulin, slower gastric emptying, increased fullness, less sugar production from the liver. Now combine all that. What does that make? It makes a perfect recipe for weight loss.